PER 0.00% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-27

  1. 3,220 Posts.
    lightbulb Created with Sketch. 259
    AKKI the oracle has spoken again: “My guess - FDA still has issues with the primate toxicity study”
    ........and of course has to be negative......
    In the all announcement he (wrongly) assume that non-clinical matter refers to toxicity.
    AKKI I start to think you presence in this forum it is not a matter of agenda but a matter of sad life.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $71.22M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.76K 160.8K

Buyers (Bids)

No. Vol. Price($)
2 25605 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 8691 1
View Market Depth
Last trade - 11.07am 16/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.